Balyasny Asset Management L.P. grew its holdings in Nutrien Ltd. (NYSE:NTR - Free Report) by 93.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 17,995 shares of the company's stock after acquiring an additional 8,690 shares during the period. Balyasny Asset Management L.P.'s holdings in Nutrien were worth $805,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also recently added to or reduced their stakes in the company. Fairway Wealth LLC bought a new position in Nutrien during the fourth quarter worth $27,000. HHM Wealth Advisors LLC increased its position in shares of Nutrien by 331.0% during the fourth quarter. HHM Wealth Advisors LLC now owns 625 shares of the company's stock valued at $28,000 after purchasing an additional 480 shares during the period. Assetmark Inc. lifted its position in shares of Nutrien by 1,437.5% during the 4th quarter. Assetmark Inc. now owns 738 shares of the company's stock worth $33,000 after buying an additional 690 shares during the period. Asset Planning Inc bought a new stake in Nutrien during the fourth quarter worth about $35,000. Finally, Exchange Traded Concepts LLC lifted its position in shares of Nutrien by 96.7% during the fourth quarter. Exchange Traded Concepts LLC now owns 846 shares of the company's stock worth $38,000 after purchasing an additional 416 shares in the last quarter. Hedge funds and other institutional investors own 63.10% of the company's stock.
Nutrien Trading Up 0.0%
NTR stock traded up $0.02 during midday trading on Monday, reaching $57.92. The company's stock had a trading volume of 705,884 shares, compared to its average volume of 2,416,438. The stock has a market cap of $28.28 billion, a PE ratio of 42.28, a price-to-earnings-growth ratio of 1.19 and a beta of 0.79. The company has a quick ratio of 0.82, a current ratio of 1.27 and a debt-to-equity ratio of 0.38. The business's 50-day simple moving average is $52.62 and its 200-day simple moving average is $50.30. Nutrien Ltd. has a 52 week low of $43.69 and a 52 week high of $60.87.
Nutrien (NYSE:NTR - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.11 earnings per share for the quarter, missing analysts' consensus estimates of $0.35 by ($0.24). The firm had revenue of $4.67 billion for the quarter, compared to the consensus estimate of $5.16 billion. Nutrien had a return on equity of 6.81% and a net margin of 2.62%. The business's revenue was down 5.4% on a year-over-year basis. During the same period last year, the company posted $0.46 EPS. As a group, sell-side analysts expect that Nutrien Ltd. will post 3.72 EPS for the current year.
Nutrien Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 18th. Shareholders of record on Monday, June 30th will be issued a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a yield of 3.76%. The ex-dividend date is Monday, June 30th. Nutrien's dividend payout ratio is currently 203.74%.
Analyst Upgrades and Downgrades
NTR has been the topic of a number of research analyst reports. Piper Sandler raised their price target on Nutrien from $58.00 to $63.00 and gave the stock an "overweight" rating in a research report on Monday, January 27th. The Goldman Sachs Group upped their target price on Nutrien from $53.00 to $59.00 and gave the stock a "sell" rating in a research note on Friday, May 9th. Wells Fargo & Company lifted their price objective on Nutrien from $56.00 to $59.00 and gave the stock an "equal weight" rating in a research note on Monday, May 12th. BNP Paribas raised Nutrien to a "strong-buy" rating in a research report on Wednesday, April 9th. Finally, Royal Bank of Canada lifted their target price on Nutrien from $60.00 to $65.00 and gave the stock an "outperform" rating in a research note on Monday, May 12th. Two research analysts have rated the stock with a sell rating, six have issued a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $61.44.
Check Out Our Latest Research Report on Nutrien
Nutrien Profile
(
Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
See Also
Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
